Experience of Adolescents With Anorexia Nervosa Towards Antidepressants
E3A
Subjective Experience of Adolescents Suffering From Anorexia Nervosa With Antidepressants
1 other identifier
observational
15
1 country
1
Brief Summary
The purpose of this study is to explore the experience of adolescents suffering from anorexia nervosa confronted with the prescription of antidepressants
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 17, 2020
CompletedFirst Posted
Study publicly available on registry
July 22, 2020
CompletedStudy Start
First participant enrolled
July 31, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 20, 2020
CompletedSeptember 12, 2025
September 1, 2025
3 months
July 17, 2020
September 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Qualitative data / Experience of taking anidepressants
Subjective experience of adolescents with anorexia nervosa about prescription of antidepressants and their effects will be obtained during the grid interview and through their describing to written questions
At the time of inclusion (Day 0)
Study Arms (1)
Adolescents with anorexia nervosa
Adolescents from 12 to 25 year old, cared for anorexia nervosa at the Maison de Solenn (Cochin hospital, Paris, France) et for whom antidepressive agents have been prescribed
Interventions
Eligibility Criteria
Adolescents (between 12 and 25 years) suffer from anorexia nervosa, at the Maison de Solenn, Cochin Hospital, Paris, France
You may qualify if:
- Adolescents aged 12 to 25
- Suffering from anorexia nervosa \[according to DSM-5 criteria\]
- Has been prescribed for a type of SSRIs antidepressant (still ongoing or interrupted at the time of the interview)
- Non-opposition to the study
You may not qualify if:
- Atypical eating disorder that do not meet DSM-5 criteria for restrictive anorexia nervosa
- Body Mass Index \< 15
- Prescribed for another antidepressant than SSRIs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maison de Solenn / Cochin Hospital
Paris, 75014, France
Related Publications (3)
Leble N, Radon L, Rabot M, Godart N. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants]. Encephale. 2017 Feb;43(1):62-68. doi: 10.1016/j.encep.2016.02.017. Epub 2016 Jul 21. French.
PMID: 27452149BACKGROUNDAnderson C, Roy T. Patient experiences of taking antidepressants for depression: a secondary qualitative analysis. Res Social Adm Pharm. 2013 Nov-Dec;9(6):884-902. doi: 10.1016/j.sapharm.2012.11.002. Epub 2012 Dec 4.
PMID: 23219056BACKGROUNDLudot-Gregoire M, David V, Carretier E, Lachal J, Moro MR, Blanchet C. Subjective Experience of Antidepressant Prescription Among Adolescents With Anorexia Nervosa. Front Psychiatry. 2022 Apr 4;13:770903. doi: 10.3389/fpsyt.2022.770903. eCollection 2022.
PMID: 35444576BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maude LUDOT, Psychiatrist
APHP, Hôpital Cochin, Maison de Solenn, F-75014 Paris, France
- STUDY CHAIR
Marie-Rose MORO, PU-PH
APHP, Hôpital Cochin, Maison de Solenn, F-75014 Paris, France
- STUDY DIRECTOR
Corinne BLANCHET, PH
APHP, Hôpital Cochin, Maison de Solenn, F-75014 Paris, France
- STUDY DIRECTOR
Jonathan LACHAL, PHU
APHP, Hôpital Cochin, Maison de Solenn, F-75014 Paris, France
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 17, 2020
First Posted
July 22, 2020
Study Start
July 31, 2020
Primary Completion
October 20, 2020
Study Completion
October 20, 2020
Last Updated
September 12, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- 6 months after publication
- Access Criteria
- Interviews will be analysed with a qualitative methodology (Interpretative Phenomenological Analysis) \- Emergent themes will be presented.
* Use of a treatment database, named Actipidos * Interview recording on a Dictaphone \[kept all over the study in a locked drawer in a medical office at the Maison de Solenn, and then destroyed\]. * Verbatim transcription, on a word-formatted file from a computer in a medical office at the Maison de Solenn; computer secured by a password. * Transcripts will be anonymized with an identical number as soon as they are created; no non-anonymized data records will be kept beyond the end of the study.